Daniel C. Sigg, MD, PhD
Daniel Sigg is CEO of FocusStart, a Twin Cities-based medical device development company. Recently, FocusStart was named New Company of the Year by the Medical Alley for its unique business model. Daniel has over 30 years of experience in the medical field, and over 20 years in the clinical, academic and industry settings. After achieving board certification in Anesthesiology, and a PhD in Physiology, Daniel began his career at Medtronic where he was co-inventor and developer of new drug device combination devices and novel therapies. Daniel served on the board of directors of LecTec (now Axogen, NASDAQ: AXGN). Subsequently, Daniel held various R&D, post-market/quality and management roles at both device as well as Pharma/Biotech companies (Medical Director at Novo Nordisk and Hospira, CEO at NanoCor). Daniel publishes, teaches and speaks regularly. Daniel holds a MD from the University of Basel and a PhD in Physiology from the UMN.